These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3015199)

  • 1. Human von Willebrand factor: a multivalent protein composed of identical subunits.
    Chopek MW; Girma JP; Fujikawa K; Davie EW; Titani K
    Biochemistry; 1986 Jun; 25(11):3146-55. PubMed ID: 3015199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain.
    Girma JP; Chopek MW; Titani K; Davie EW
    Biochemistry; 1986 Jun; 25(11):3156-63. PubMed ID: 3015200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide bonds required to assemble functional von Willebrand factor multimers.
    Dong Z; Thoma RS; Crimmins DL; McCourt DW; Tuley EA; Sadler JE
    J Biol Chem; 1994 Mar; 269(9):6753-8. PubMed ID: 8120035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
    Cooney KA; Lyons SE; Ginsburg D
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
    Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.
    Bockenstedt P; Greenberg JM; Handin RI
    J Clin Invest; 1986 Mar; 77(3):743-9. PubMed ID: 2936763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
    De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic studies on the structure of bovine von Willebrand factor.
    Mascelli MA; Kirby EP
    Biochemistry; 1988 Feb; 27(4):1274-84. PubMed ID: 2452652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of human platelet von Willebrand factor.
    Williams SB; McKeown LP; Krutzsch H; Hansmann K; Gralnick HR
    Br J Haematol; 1994 Nov; 88(3):582-91. PubMed ID: 7819071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
    Dent JA; Galbusera M; Ruggeri ZM
    J Clin Invest; 1991 Sep; 88(3):774-82. PubMed ID: 1909351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
    Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.
    Carew JA; Quinn SM; Stoddart JH; Lynch DC
    J Clin Invest; 1992 Dec; 90(6):2258-67. PubMed ID: 1469086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Domain structure of human von Willebrand factor, and its modulators involved in the platelet adhesion process in vitro].
    Fujimura Y; Fukui H; Usami Y; Titani K
    Rinsho Ketsueki; 1991 May; 32(5):475-80. PubMed ID: 1870263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
    Hamilton KK; Fretto LJ; Grierson DS; McKee PA
    J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII.
    Wise RJ; Dorner AJ; Krane M; Pittman DD; Kaufman RJ
    J Biol Chem; 1991 Nov; 266(32):21948-55. PubMed ID: 1939217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.